You have 9 free searches left this month | for more free features.

Waldenstrom Macroglobulinemia

Showing 1 - 25 of 503

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory Trial

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • +2 more
  • (no location specified)
Jul 18, 2023

Waldenstrom Macroglobulinemia Trial in Napoli

Completed
  • Waldenstrom Macroglobulinemia
    • Napoli, Italy
      University of Naples "Federico II" Naples, Italy, 80100 Contact:
    Oct 10, 2023

    Waldenström's Macroglobulinemia Trial (zanubrutinib,bendamustine,rituximab)

    Not yet recruiting
    • Waldenström's Macroglobulinemia
    • (no location specified)
    Aug 4, 2023

    Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • Zanubrutinib, Bendamustine and Rituximab
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jun 13, 2023

    Waldenstrom Macroglobulinemia Trial (Zanubrutinib)

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • (no location specified)
    Nov 28, 2022

    Waldenstrom's Macroglobulinemia Trial in Houston (Bortezomib, Rituximab, Valacyclovir)

    Active, not recruiting
    • Waldenstrom's Macroglobulinemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 5, 2022

    Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • B-Cell Lymphoproliferative Disorder
    • Boston, Massachusetts
    • +2 more
    Feb 18, 2023

    Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)

    Completed
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
    • +1 more
    Dec 5, 2022

    Waldenstrom Macroglobulinemia Trial (Venetoclax; Rituximab, DRC)

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • Venetoclax; Rituximab
    • DRC
    • (no location specified)
    Nov 4, 2022

    Waldenstrom Macroglobulinemia Trial in China (Ibrutinib)

    Active, not recruiting
    • Waldenstrom Macroglobulinemia
    • Changchun, China
    • +5 more
    Jan 27, 2023

    Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
    • Waldenstrom Macroglobulinemia (WM)
    • Shingrix vaccine
    • Rochester, New York
      University of Rochester
    Jan 9, 2023

    Waldenstrom Macroglobulinemia Trial in Japan (Ibrutinib, Rituximab)

    Active, not recruiting
    • Waldenstrom Macroglobulinemia
    • Chiba, Japan
    • +8 more
    Jan 27, 2023

    Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,

    Not yet recruiting
    • Cancer Prevention
    • +5 more
    • Prolonged Fasting Intervention
    • EDUCATION CONTROL
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Dec 28, 2022

    Waldenstrom's Macroglobulinemia Trial in Boston (Ulocuplumab, Ibrutinib)

    Active, not recruiting
    • Waldenstrom's Macroglobulinemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jun 20, 2022

    Waldenstrom Macroglobulinemia Trial in Canada (Acalabrutinib, Bendamustine, Rituximab)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • Calgary, Alberta, Canada
    • +8 more
    Nov 9, 2022

    Waldenström's Macroglobulinemia Trial in Ulm (Dexamethasone, Rituximab, Cyclophosphamide, Dexamethasone, Rituximab,

    Active, not recruiting
    • Waldenström's Macroglobulinemia
    • Dexamethasone, Rituximab, Cyclophosphamide
    • Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib
    • Ulm, Germany
      University Hospital Ulm
    May 26, 2022

    Zanubrutinib in Waldenström's Macroglobulinemia (ARIADNE)

    Recruiting
    • Waldenström's Macroglobulinemia
    • Salzburg, Austria
    • +1 more
    May 2, 2022

    Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • DASATINIB
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 22, 2022

    Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

    Not yet recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +5 more
    • Routine care as per site standard.
    • (no location specified)
    Sep 15, 2023

    Questionnaire and Tissue Banking For Multiple Myeloma,

    Active, not recruiting
    • Multiple Myeloma
    • +3 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Mar 15, 2022

      Waldenström's Macroglobulinemia Trial in Busan (Lenalidomide, Bortezomib, Rituximab, Dexamethasone)

      Recruiting
      • Waldenström's Macroglobulinemia
      • Lenalidomide, Bortezomib, Rituximab, Dexamethasone
      • Busan, Sue-gu, Korea, Republic of
        Kosin University Gospel Hospital
      Mar 31, 2022

      B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • +4 more
      • Non-Interventional Study
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Nov 22, 2023

      Waldenstrom Macroglobulinemia Trial in Hackensack (Carfilzomib, Rituximab, Dexamethasone)

      Completed
      • Waldenstrom Macroglobulinemia
      • Hackensack, New Jersey
        John Theurer Cancer Center at Hackensack University Medical Cent
      Mar 18, 2022

      Relapsed/Refractory Waldenstrom Macroglobulinemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Burkitt

      Not yet recruiting
      • Relapsed/Refractory Waldenstrom Macroglobulinemia
      • +3 more
      • Brexucabtagene Autoleucel
      • +2 more
      • (no location specified)
      Sep 8, 2022